Publications for Ulrika NilssonCo-author map based on ISI articles 2007-
Publications mentioned in social media 1 times*Journal ArticlesUlrika Nilsson, Niina Saarinen, Annelie Abrahamsson, Tarja Nurmi, Sofia Engblom and Charlotta Dabrosin Tamoxifen and Flaxseed Alter Angiogenesis Regulators in Normal Human Breast Tissue In Vivo Altmetric usage: 1 PLoS ONE, 2011, 6(9), . Fulltext Web of Science® Times Cited: 14Ulrika Nilsson, Annelie Abrahamsson and Charlotta Dabrosin Angiogenin Regulation by Estradiol in Breast Tissue: Tamoxifen Inhibits Angiogenin Nuclear Translocation and Antiangiogenin Therapy Reduces Breast Cancer Growth In vivo Clinical Cancer Research, 2010, 16(14), 3659-3669. Web of Science® Times Cited: 19Ulrika Nilsson, Jill A. Jönsson and Charlotta Dabrosin Tamoxifen decreases extracellular TGF-beta 1 secreted from breast cancer cells - A post-translational regulation involving matrix metalloproteinase activity Experimental Cell Research, 2009, 315(1), 1-9. Fulltext Web of Science® Times Cited: 10Ulrika W. Nilsson, Stina Garvin and Charlotta Dabrosin MMP‐2 and MMP‐9 activity is regulated by estradiol and tamoxifen in cultured human breast cancer cells Breast Cancer Research and Treatment, 2007, 102(3), 253-261. Web of Science® Times Cited: 42Ulrika W. Nilsson, J. A. Jönsson and Charlotta Dabrosin Tamoxifen downregulatesTGF‐β1 protein levels via matrix metalloproteinase activity in breast cancer in vivo , 2007, , . Stina Garvin, Ulrika W. Nilsson, Fredrik R. M. Huss, Gunnar Kratz and Charlotta Dabrosin Estradiol increases VEGF in normal human breast studied by whole-tissue culture Cell Tissue Research, 2006, 325(2), 245-251. Web of Science® Times Cited: 17Ulrika W. Nilsson and Charlotta Dabrosin Estradiol and tamoxifen regulate endostatin generation via matrix metalloproteinase activity in breast cancer in vivo Cancer Research, 2006, 66(9), 4789-4794. Web of Science® Times Cited: 39Stina Garvin, Ulrika W. Nilsson and Charlotta Dabrosin Effects of estradiol and tamoxifen on VEGF, soluble VEGFR-1, and VEGFR-2 in breast cancer and endothelial cells British journal of cancer, 2005, 93(9), 1005-1010. Web of Science® Times Cited: 49Conference ArticlesUlrika Nilsson and Charlotta Dabrosin Anti-angiogenic effects of tamoxifen in breast cancer by decreased secretion and reduced nuclear accumulation of angiogenin CANCER RESEARCH ISSN 0008-5472: Volume 69 Issue 2, 2009. Ph.D. ThesesUlrika W. Nilsson Effects of sex steroids and tamoxifen on matrix metalloproteinase activity and generation of endostatin in the breast 2007. Fulltext * Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.
Publications mentioned in social media 1 times*
* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.